Apowiser Raises $1.5M In Seed Funding from Longliv Ventures, a Member of CK Hutchison Holdings, to Expand the Global Reach of its Novel Digital Platform that Empowers Consumers to...
RA'ANANA, Israel, June 21, 2022 /PRNewswire/ -- Apowiser, an early-stage Israeli start-up that has developed PharmAssist, a chatbot-based system to support customers in the online purchase of Over-the-Counter (OTC) drugs announced today a $1.5 million seed funding round led by Longliv Ventures, a member of CK Hutchinson Holdings Limited. Co-founded in 2021 by Prof. Eyal Schwartzberg,...
Prof. Cho, head of the lung cancer center at Yonsei Cancer Hospital, “J INTS BIO’s new oral administration 4th generation EGFR TKI ‘JIN-A02’ expected to be a game changer”
SEOUL, South Korea, June 21, 2022 /PRNewswire/ -- Prof. Cho Byoung-chul at Yonsei University College of Medicine (Director, Lung Cancer Center, Yonsei Cancer Hospital) is one of the most influential researchers in the lung cancer field and is involved in the development of innovative new drugs globally. Although the survival rate of patients with EGFR mutation positive NSCLC has...
Innovative Business Models in Digital Health Improve Efficiency Across the Care Continuum
Digital health solutions will become inevitable to support better healthcare outcomes at lower costs, says Frost & Sullivan SAN ANTONIO, June 21, 2022 /PRNewswire/ -- The increased number of patients using digital health tools, such as telehealth and other enterprise IT solutions, empowered consumers to manage their health and accelerated global digital health market growth, according to Frost & Sullivan's...
Nippon Express Launches New Transport Service Using Environment-friendly Isothermal Packaging
TOKYO, June 21, 2022 /PRNewswire/ -- -First Japanese Logistics Company to Collaborate with EMBALL'ISO, Experienced in Vaccine Transport- Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., has become the first Japanese logistics company to collaborate with EMBALL'ISO, a French company with a proven track record in vaccine transport, by launching a new international...
Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform
BEIJING, June 21, 2022 /PRNewswire/ -- Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new vaccines and therapies, announced the completion of a US$42 million Series A financing round. The round was co-led by a well-known industrial investment firm and MSA Capital, with participation from Sherpa Healthcare Partners, 3H Health...
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma
SAN FRANCISCO, INDIANAPOLIS and SUZHOU, China, June 21, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and other major diseases, and Eli Lilly and Company ("Lilly", NYSE: LLY) today announced that the Center for Drug Evaluation (CDE) of China's...
Shaklee Malaysia Awarded the Trusted Vitamins and Health Supplements Brand in Malaysia
KUALA LUMPUR, Malaysia, June 21, 2022 /PRNewswire/ -- A well-loved vitamins and health supplements brand, Shaklee has been voted 2022 Trusted Brand in Malaysia in a survey by Reader's Digest. Shaklee Malaysia awarded the Trusted Brand Award in Vitamins and Health Supplements category According to Reader's Digest, the survey sees Shaklee Malaysia emerge as Gold Award in...
3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform
REYKJAVIK, Iceland, June 20, 2022 /PRNewswire/ -- 3Z, a Reykjavik based drug discovery company is pleased to announce the closure of a $2 million funding round led by seasoned investors in pharmaceuticals and medical technology. The just closed funding will accelerate finalization of preclinical studies on 3Z's lead therapeutic candidates in ADHD and insomnia. Using its unique zebrafish screening platform,...
Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin’s Lymphoma
ACE1831 is a potential antibody‑armed allogeneic gamma delta T cell therapy developed using Acepodia's unique antibody-cell conjugation (ACC) technology as an optimized T cell engager platform to treat patients with non-Hodgkin's lymphoma ALAMEDA, Calif. and TAIPEI, Taiwan, June 20, 2022 /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) platform...
Infinitus co-organizes Norm Management Day Event in move to drive growth of the health food sector
GUANGZHOU, China, June 20, 2022 /PRNewswire/ -- On June 16, Chinese herbal health products provider Infinitus (China) Company Ltd. (Infinitus) and Xinhuanet co-hosted the online 2022 Positive Energy Campaign for China's health food industry and the 6.16 Infinitus Norm Management Day Live Broadcast Sharing Event. This is the sixth year in a row that the company has hosted the event. ...
